Skip to content
Back to FLNA

Filana Therapeutics, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
6
Purchases
6
Sales
0
Purchase value
$997.08K
Sale value
$0.00

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Richard BarryDirector · President & CEO
4
Filed Oct 1, 2026Period of report Sep 29, 20260001437749-26-031654
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseSep 30, 2026
Common StockF2100,000$0.92$92.00K1,337,964IndirectBy Trust
PurchaseSep 29, 2026
Common StockF1206,813$0.90$186.13K1,237,964IndirectBy Trust
Filing footnotes · 2
  1. F1The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $0.86 to $0.94 per share. The reporting person undertakes to provide to Filana, any security holder of Filana or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote.
  2. F2The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $0.91 to $0.93 per share. The reporting person undertakes to provide to Filana, any security holder of Filana or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote.
Open on SEC EDGAR
Richard BarryDirector · President & CEO
4
Filed Sep 30, 2026Period of report Sep 28, 20260001437749-26-031597
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseSep 28, 2026
Common StockF193,091$0.84$78.20K1,031,151IndirectBy Trust
Filing footnotes · 1
  1. F1The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $0.82 to $0.85 per share. The reporting person undertakes to provide to Filana, any security holder of Filana or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote.
Open on SEC EDGAR
Robert Eugene Anderson JrDirector
4
Filed Nov 25, 2025Period of report Nov 24, 20250001437749-25-036321
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseNov 24, 2025
Common Stock8,600$2.90$24.94K8,600Direct
Open on SEC EDGAR
Richard BarryDirector · President & CEO
4
Filed Nov 24, 2025Period of report Nov 20, 20250001437749-25-036125
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseNov 20, 2025
Common StockF1150,000$2.76$414.00K938,060IndirectBy Trust
Filing footnotes · 1
  1. F1The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $2.74 to $2.80 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote.
Open on SEC EDGAR
Richard BarryDirector · President & CEO
4
Filed Nov 20, 2025Period of report Nov 19, 20250001437749-25-035882
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseNov 19, 2025
Common StockF173,385$2.75$201.81K788,060IndirectBy Trust
Filing footnotes · 1
  1. F1The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $2.73 to $2.75 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.